Bausch Health Companies Inc. (BHC) has a consensus analyst rating of Buy, based on 38 analysts covering the stock. Of those, 19 recommend buying, 15 recommend holding, and 4 recommend selling.
The analyst consensus price target for BHC is $8.00, representing a +40.8% upside from the current price of $5.68. Price targets range from a low of $8.00 to a high of $8.00.
